Expansion Therapeutics
Jennifer Visco, CPA is the Vice President, Finance and Business Operations at Expansion Therapeutics. She joined Expansion in 2020, bringing over 25 years of accounting and finance experience. Prior to joining Expansion, she was the Finance Director at MEDScience, a program of Harvard Medical School. Previously, Jennifer was Partner and CCO at Martingale Asset Management. She started her career as a Senior Associate at PricewaterhouseCoopers. Jen holds advisory and executive board positions with several educational, sporting and non-profit organizations. Jen received her B.S. in Accounting and Business Management from Babson College and is a Certified Public Accountant.
This person is not in any offices
Expansion Therapeutics
2 followers
Expansion Therapeutics is a drug discovery and development company pursuing the vast potential of small molecule medicines for RNA-mediated diseases. Expansion has assembled the intellectual property, know-how, and proprietary enabling technologies and tools necessary to facilitate the creation of potent and specific small molecule binders of RNA. Through this unique platform, Expansion is building a portfolio of novel RNA-targeted drug candidates with activity across a broad number of disease indications. The company’s initial development focus is on therapies for patients with expansion repeat diseases who currently have limited and unsatisfactory treatment options. Expansion is based in San Diego, California and Jupiter, Florida.